~~<i id='1606F9098B'><strike id='1606F9098B'><tt id='1606F9098B'><pre id='1606F9098B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：entertainment 2025-10-01 15:40:13 - browse：6

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met.

AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Headspace, Meta partner to launch VR meditation app for Quest

Wikipedia

hotspot

focus

hotspot

entertainment

knowledge

VicePresidentKamalaHarrisstandsasHouseSpeakerMikeJohnsonofLouisianawatchesasPresidentBidendeliversth

WSS

Future doctors need a strong humanities education

Immunocompromised patients offer clues on chronic Covid

Printout prescription drug information shouldn’t go digital

Flu vaccine reformulation won't be easy, manufacturers warn

TikTok, Instagram influencers need more rules for drug ads

The problem with charging patients to message their doctors

focus

knowledge

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

The inclusion problem at the heart of rehabilitation research

Medicare details structure of new drug price negotiation program

Cardiologists urge adding sexual orientation, gender identity to health records

Medical records are filled with copy

Amylyx ALS drug fails large clinical trial

After affirmative action ruling, medical educators look to 'holistic review'

TikTok, Instagram influencers need more rules for drug ads

Medicare proposal to cover medical devices draws a mixed reaction

What it’s like to watch children die of measles

hotspot

CDC marks new Covid

Printout prescription drug information shouldn’t go digital

TikTok, Instagram influencers need more rules for drug ads

CDC marks new Covid

Head of FDA's diagnostics center, who led through Covid, retires

Change Healthcare payments predicted restored March 15

focus

hotspot

entertainment

knowledge